Xeljanz Xr
Xeljanz Xr ingredients
| Active ingredient | Strength |
|---|---|
| Tofacitinib Citrate | 11 mg/1, 22 mg/1 |
What Xeljanz Xr is used for
The FDA lists the approved uses on the official label (below). In the EU, tofacitinib is approved as Xeljanz for:
Rheumatoid arthritisTofacitinib in combination with methotrexate (MTX) is indicated for the treatment of moderate to severe active rheumatoid arthritis (RA) in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying antirheumatic drugs (DMARDs) (see section 5.1). Tofacitinib can be given as monotherapy in case of intolerance to MTX or when treatment with MTX is inappropriate (see sections 4.4 and 4.5). Psoriatic arthritisTofacitinib in combination with MTX is indicated for the treatment of active psoriatic arthritis (PsA) in adult patients who have had an inadequate response or who have been intolerant to a prior disease modifying antirheumatic drug (DMARD) therapy (see section 5.1). Ulcerative colitisTofacitinib is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (UC) who have had an ina…
EU wording from the European Medicines Agency; US approved uses can differ.
Key facts
- Brand
- Xeljanz Xr
- Generic name
- Tofacitinib
- Made by
- Pfizer Laboratories Div Pfizer Inc
- Forms
- Tablet, Extended Release, Tablet, Film Coated, Extended Release
- Given
- Oral
- Drug class
- Janus Kinase Inhibitor
- FDA approval
- New drug application (NDA) NDA208246
- On the US market since
- 2016
Official information
- MedlinePlus drug information (search for Tofacitinib)
In India
- Tofacitinib citrate: 32 brands in India
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Xeljanz Xr?
Xeljanz Xr (Tofacitinib) is a cancer medicine made by Pfizer Laboratories Div Pfizer Inc, approved by the US FDA.
What are the ingredients of Xeljanz Xr?
Xeljanz Xr contains Tofacitinib Citrate (11 mg/1, 22 mg/1).
Is Xeljanz Xr approved in Europe?
The same active substance is approved in the EU as Xeljanz.
From the FDA National Drug Code directory (open.fda.gov, public domain) and the European Medicines Agency medicines list. Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA